Drägerwerk AG & Co. KGaA (FRA:DRW3)

Germany flag Germany · Delayed Price · Currency is EUR
88.40
-0.80 (-0.90%)
Last updated: Jun 3, 2026, 5:35 PM CET
Market Cap1.51B +37.0%
Revenue (ttm)3.51B +4.2%
Net Income153.02M +32.8%
EPSn/a
Shares Out n/a
PE Ratio9.86
Forward PE10.59
Dividend2.27 (2.47%)
Ex-Dividend DateMay 11, 2026
Volume8,126
Open88.40
Previous Close89.20
Day's Range86.70 - 88.70
52-Week Range62.30 - 98.90
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJul 30, 2026

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1889
Employees 16,033
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol DRW3

Financial Performance

In 2025, Drägerwerk AG & Co. KGaA's revenue was 3.48 billion, an increase of 3.29% compared to the previous year's 3.37 billion. Earnings were 139.50 million, an increase of 12.13%.

Financial Statements

News

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q1 2026

EBIT and Free Cash Flow rose sharply in Q1 2026, with strong sales growth and improved margins. Both divisions contributed to higher earnings, and guidance for the year remains positive, with no material impact expected from tariffs or geopolitical risks.

4 weeks ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: Investor presentation

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 30, 2026.

4 weeks ago - Filings

Drägerwerk AG & Co. KGaA Quarterly report: Q1 2026

Drägerwerk AG & Co. KGaA has published its Q1 2026 quarterly earnings report on April 30, 2026.

4 weeks ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q1 2026

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.

4 weeks ago - Filings

Drägerwerk AG & Co. KGaA Earnings release: Q1 2026

Drägerwerk AG & Co. KGaA released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Drägerwerk AG & Co. KGaA Transcript: German Select VII Conference

The company reported record sales and margin growth in 2025, driven by strong operational performance and innovation in open medical ecosystems. Defense and Safety segments are set for significant expansion, while margin improvement will rely on top-line growth, pricing, and cost control.

7 weeks ago - Transcripts

Drägerwerk AG & Co. KGaA Slides: German Select VII Conference

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.

7 weeks ago - Filings

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q4 2025

Record net sales and EBIT were achieved in 2025, with both divisions and all regions contributing to growth. Despite significant tariff and currency headwinds, profitability improved, and strong cash flow supported higher dividends and reduced debt.

2 months ago - Transcripts

Drägerwerk AG & Co. KGaA Annual report: Q4 2025

Drägerwerk AG & Co. KGaA has published its Q4 2025 annual report on March 24, 2026.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Earnings release: Q4 2025

Drägerwerk AG & Co. KGaA released its Q4 2025 earnings on March 24, 2026, summarizing the period's financial results.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Annual report: Q4 2025

Drägerwerk AG & Co. KGaA has published its Q4 2025 annual report on March 24, 2026.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q4 2025

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 24, 2026.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Slides: Investor presentation

Drägerwerk AG & Co. KGaA has posted slides in relation to its latest quarterly earnings report, which was published on March 24, 2026.

2 months ago - Filings

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q3 2025

Strong order intake and sales growth drove robust earnings in the first nine months of 2025, with both Medical and Safety divisions contributing. Guidance was raised to the upper end of the range, though FX and regional headwinds remain risks.

7 months ago - Transcripts

Drägerwerk AG & Co. KGaA Quarterly report: Q3 2025

Drägerwerk AG & Co. KGaA has published its Q3 2025 quarterly earnings report on October 29, 2025.

7 months ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q3 2025

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 29, 2025.

7 months ago - Filings

Drägerwerk AG & Co. KGaA Earnings Call Transcript: Q2 2025

H1 2025 saw stable net sales and strong order intake, but EBIT declined due to the absence of prior year one-offs and currency/tariff headwinds. Guidance for 2025 is confirmed, with management confident in margin improvement despite ongoing challenges.

11 months ago - Transcripts

Drägerwerk AG & Co. KGaA Quarterly report: Q2 2025

Drägerwerk AG & Co. KGaA has published its Q2 2025 quarterly earnings report on July 29, 2025.

11 months ago - Filings

Drägerwerk AG & Co. KGaA Slides: Q2 2025

Drägerwerk AG & Co. KGaA has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 29, 2025.

11 months ago - Filings